[1] KIM HS,El-SERAG HB. The epidemiology of hepatocellular carcinoma in the USA[J]. Curr Gastroenterol Rep,2019,21(4):17.
|
[2] MEIER JC,HAENDLER B,SEIDEL H,et al. Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis[J]. Cancer Med,2015,4(2):253-267.
|
[3] LEE ES,KIM SH,KIM HJ,et al. Growth differentiation factor15 predicts chronic liver disease severity[J]. Gut Liver,2017,11(2):276-282.
|
[4] National Health and Family Planning Commission of the People's Republic of China. Diagnosis,management,and treatment of hepatocellular carcinoma(V2017)[J]. J Clin Hepatol,2017,33(8):1419-1431.(in Chinese)中华人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范(2017年版)[J].临床肝胆病杂志,2017,33(8):1419-1431.
|
[5] CAO GL,HU XY,GENG WM,et al. Application of multiple serum tumor markers on the diagnosis of early primary liver cancer[J/CD]. Chin J Liver Dis(Electronic Version),2018,10(4):12-16.(in Chinese)曹国磊,胡小云,耿伟明,等.血清肿瘤标志物联合检测在早期原发性肝癌诊断的应用[J/CD].中国肝脏病杂志(电子版),2018,10(4):12-16.
|
[6] GUAN GW,YAO MJ,QIAN XJ,et al. Value of combined measurement of alpha-fetoprotein and alpha-fetoprotein L3%in the diagnosis of hepatocellular carcinom[J]. J Clin Hepatol,2019,35(7):1514-1519.(in Chinese)关贵文,姚明解,钱相君,等.AFP和AFP-L3%联合检测在肝细胞癌诊断中的应用价值[J].临床肝胆病杂志,2019,35(7):1514-1519.
|
[7] XI LT,ZHANG HX,WU AR,et al. Value of combined measurement of serum alpha-fetoprotein,Dickkopf-1,and cytoskeleton-associated protein 4 in diagnosis of hepatocellular carcinoma[J]. J Clin Hepatol,2019,35(6):1276-1279.(in Chinese)奚黎婷,张慧娴,吴爱荣,等.血清甲胎蛋白、Dickkopf相关蛋白1、细胞骨架蛋白4联合检测对肝细胞癌的诊断价值[J].临床肝胆病杂志,2019,35(6):1276-1279.
|
[8] XIE F,YU YC,XUE Z,et al. Screening strategy for primary hepatocellular carcinoma based on different combinations of protein induced by vitamin K absence or antagonist-Ⅱ,alpha-fetoprotein,and alpha-fetoprotein-L3[J]. J Clin Hepatol,2019,35(9):1975-1979.(in Chinese)谢芳,于乐成,薛珠,等.基于PIVKA-Ⅱ、AFP和AFP-L3不同组合模式的肝细胞癌筛查策略探讨[J].临床肝胆病杂志,2019,35(9):1975-1979.
|
[9] WALLIN U,GLIMELIUS B,JIRSTROM K,et al. Growth differentiation factor 15:A prognostic marker for recurrence in colorectal cancer[J]. Br J Cancer,2011,104(10):1619-1627.
|
[10] LEE DH,YANG Y,LEE SJ,et al. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system[J]. Cancer Res,2003,63(15):4648-4655.
|
[11] ALBERTONI M,SHAW PH,NOZAKI M,et al. Anoxia induces macrophage inhibitory cytokine-1(MIC-1)in glioblastoma cells independently of p53 and HIF-1[J]. Oncogene,2002,21(27):4212-4219.
|
[12] BAEK SJ,KIM KS,NIXON JB,et al. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities[J].Mol Pharmacol,2001,59(4):901-908.
|
[13] ZHANG L,YANG X,PAN HY,et al. Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in vitro cell proliferation in oral squamous cell carcinoma[J]. Oral Oncol,2009,45(7):627-632.
|
[14] WANG L,LIU Y,LI W,et al. Growth differentiation factor 15promotes cell viability,invasion,migration,and angiogenesis in human liver carcinoma cell line HepG2[J]. Clin Res Hepatol Gastroenterol,2017,41(4):408-414.
|
[15] LIU X,CHI X,GONG Q,et al. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma[J]. PLo S One,2015,10(5):e127518.
|
[16] CHEN GG,HO RL,WONG J,et al. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein(AFP)gene and its significance in hepatocellular carcinoma(HCC)[J]. Eur J Surg Oncol,2007,33(7):882-886.
|
[17] ZHU HJ,GU YF. Significance of combined detection of AFP,CA199,CA50 and ferr in the diagnosis of primary liver cancer[J/CD]. Chin J Clin Lab Sci(Electronic Edition),2019,8(4):268-269.(in Chinese)朱慧婧,顾益凤.血清中AFP、CA199、CA50和Ferr联合检测在原发性肝癌诊断中的意义[J/CD].临床检验杂志(电子版),2019,8(4):268-269.
|